CVS vs BMY
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Sep 09, 2026
CVS
BMY
Investment Advisor Scores
BMY
AI Analyst Insights
Detailed Metrics Comparison
| Metric | CVS | BMY | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 11.4943 | 10.4275 | BMY |
| PEG Ratio | 0.2275 | 2.5432 | CVS |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 7.1% | 5.7% | CVS |
| Earnings Growth | 188.8% | 153.1% | CVS |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 49.6/100 | 35.9/100 | CVS |
| Profit Margin | 1.2% | 18.9% | BMY |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | SELL | CVS |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CVS
MarkdownPrice below a falling SMA50 (slope -2.0%), weak momentum, RSI 43
BMY
NeutralMixed signals - no dominant trend phase, RSI 42
Fundamentals Snapshot
| Metric | CVS | BMY |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 11.1 | 9.7 |
| Trailing P/E | 25.2 | 14.0 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.1% |
| Gross Margin | 0.1% | 0.7% |
| Operating Margin | 0.0% | 0.3% |
| EPS | 3.78 | 4.54 |
| Dividend Yield | 0.03% | 0.04% |